Antibodies to Optic Nerve Glycosaminoglycans in Glaucoma
About the Research Project
Program
Award Type
Standard
Award Amount
$50,000
Active Dates
April 01, 1999 - March 31, 2001
Grant ID
G1999016
Summary
Although high intraocular pressure (IOP) is frequently associated with glaucoma, some people have the disease without high IOP. In these cases, it has been suggested that nerve death and damage to the optic nerve may result from a person’s own antibodies (autoimmunity) that mistakenly attack the optic nerve and/or its blood supply. Dr. Wax has provided evidence that some glaucoma patients have antibodies that interact with important molecules (called glycosaminoglycans) that help form support structures for the optic nerve. He will now perform a detailed analysis to further characterize the specificity of these antibodies and determine whether there are changes in the glycosaminoglycans of patients with the antibodies. In addition, he will correlate the extent of antibody reactivity to glycosaminoglycans with optic nerve damage. The goal of this study is to confirm the hypothesis that autoimmunity plays a role in glaucoma.
Related Grants
National Glaucoma Research
Measuring the Effects of Visual Stimuli on Retinal Blood Vessels and Flow
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Stuart Gardiner, PhD
Current Organization
Good Samaritan Foundation, Legacy Health System
Measuring the Effects of Visual Stimuli on Retinal Blood Vessels and Flow
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Stuart Gardiner, PhD
Current Organization
Good Samaritan Foundation, Legacy Health System
National Glaucoma Research
Reducing Inflammation to Protect Vision in Glaucoma
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Cátia Gomes, PhD
Current Organization
Indiana University School of Medicine
Reducing Inflammation to Protect Vision in Glaucoma
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Cátia Gomes, PhD
Current Organization
Indiana University School of Medicine
National Glaucoma Research
Novel Visualization of Aqueous Outflow: Uncovering Glaucoma Mechanisms and Therapeutic Targets
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Tyson Kim, MD, PhD
Current Organization
University of California, San Francisco
Novel Visualization of Aqueous Outflow: Uncovering Glaucoma Mechanisms and Therapeutic Targets
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Tyson Kim, MD, PhD
Current Organization
University of California, San Francisco